<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        77-5286-20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Ticopex
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TEICOPLANIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        powder for solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        61.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MS Pharma " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MS Pharma 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MS Pharma Saudi (MSPS)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01XA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>TICOPEX<sup>&reg;</sup> </strong>is an antibiotic. It contains a medicine called &lsquo;teicoplanin&rsquo;. It works by killing the bacteria that cause infections in your body.</p><p>Ticopex is used in adults and children (including newborn babies) to treat bacterial infections of:</p><p>&bull;&nbsp;&nbsp; the skin and underneath the skin - sometimes called &lsquo;soft tissue&rsquo;</p><p>&bull;&nbsp;&nbsp; the bones and joints</p><p>&bull;&nbsp;&nbsp; the lung</p><p>&bull;&nbsp;&nbsp; the urinary tract</p><p>&bull;&nbsp;&nbsp; the heart - sometimes called &lsquo;endocarditis&rsquo;</p><p>&bull;&nbsp;&nbsp; the abdominal wall - peritonitis</p><p>&bull;&nbsp;&nbsp; the blood, when caused by any of the conditions listed above</p><p><strong>TICOPEX<sup>&reg;</sup> </strong>can be used to treat some infections caused by &lsquo;Clostridium difficile&rsquo; bacteria in the gut. For this, the solution is taken by mouth</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use TICOPEX<sup>&reg;</sup> if:</p><p>&bull;&nbsp;&nbsp; you are allergic to telcoplanin or any of the other ingredients of this medicine (listed in section 6).</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor, pharmacist or nurse before you are given <strong>TICOPEX<sup>&reg;</sup> </strong>if:</p><p>&bull;&nbsp;&nbsp; you are allergic to an antibiotic called &lsquo;vancomycin&rsquo;</p><p>&bull;&nbsp;&nbsp; you have had a flushing of your upper part of your body (red man syndrome)</p><p>&bull;&nbsp;&nbsp; you have a decrease in platelet count (thrombocytopenia)</p><p>&bull;&nbsp;&nbsp; you have kidney problems</p><p>&bull;&nbsp;&nbsp; you are taking other medicines which may cause hearing problems and/or kidney problems. You may have regular tests to check if your kidneys and/or liver are working properly (see &lsquo;Other medicines and <strong>TICOPEX<sup>&reg;</sup></strong>&rsquo;).&bull; if you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of Phenytoin sodium, you must not be re-started on Phenytoin sodium at any time.</p><p>If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before you are given <strong>TICOPEX<sup>&reg;</sup></strong>.</p><p>Tests</p><p>During treatment you may have tests to check your blood, your kidneys and/or your hearing. This is more likely if:</p><p>&bull;&nbsp;&nbsp; your treatment will last for a long time</p><p>&bull;&nbsp;&nbsp; you have a kidney problem</p><p>&bull;&nbsp;&nbsp; you are taking or may take other medicines that may affect your nervous system, kidneys or hearing.</p><p>In people who are given Ticopex for a long time, bacteria that are not affected by the antibiotic may grow more than normal - your doctor will check for this.</p><p>Other medicines and Ticopex <sup>&reg;</sup></p><p>Tell your doctor, pharmacist or nurse if you are using, have recently used or might use any other medicines. This is because <strong>Ticopex</strong> <strong><sup>&reg;</sup> </strong>can affect the way some other medicines work. Also, some medicines can affect the way <strong>Ticopex</strong> works. In particular, tell your doctor, pharmacist or nurse if you are taking the following medicines:</p><p>&bull;&nbsp;&nbsp; Aminoglycosides as they must not be mixed together with <strong>Ticopex</strong> <strong><sup>&reg;</sup> </strong>in the same injection. They may also cause hearing problems and/or kidney problems.</p><p>&bull;&nbsp;&nbsp; amphotericin B - a medicine that treats fungal infections which may cause hearing problems and/or kidney problems</p><p>&bull;&nbsp;&nbsp; ciclosporin - a medicine that affects the immune system which may cause hearing problems and/or kidney problems</p><p>&bull;&nbsp;&nbsp; cisplatin - a medicine that treats malignant tumors which may cause hearing problems and/or kidney problems.</p><p>&bull;&nbsp;&nbsp; water tablets (such as furosemide) - also called &lsquo;diuretics&rsquo; which may cause hearing problems and/or kidney problems.</p><p>If any of the above apply to you, (or you are not sure), talk to your doctor, pharmacist or nurse before being given <strong>Ticopex</strong> <strong><sup>&reg;</sup></strong>.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant, think that you might be pregnant or are planning to have a baby, ask your doctor, pharmacist or nurse for advice before being given this medicine. They will decide whether or not you are given this medicine while you are pregnant. There may be a potential risk of inner ear and kidney problems.</p><p>Tell your doctor if you are breast-feeding, before being given this medicine. He/she will decide whether or not you can keep breast-feeding, while you are given <strong>Ticopex</strong> <strong><sup>&reg;</sup></strong>.</p><p>Studies in animal reproduction have not shown evidence of fertility problems.</p><p><strong>Driving and using machines</strong></p><p>You may have headaches or feel dizzy while being treated with <strong>Ticopex</strong> <strong><sup>&reg;</sup></strong>. If this happens, do not drive or use any tools or machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The recommended dose is Adults and children (12 years and over) with no kidney problems</strong></p><p><strong>Skin and soft tissue, lung and urinary tract infections</strong></p><p>&bull;&nbsp;&nbsp; Starting dose (for the first three doses): 6 mg for every kilogram of body weight, given every 12 hours, by injection into a vein or muscle</p><p>&bull;&nbsp;&nbsp; Maintenance dose: 6 mg for every kilogram of body weight, given once a day, by injection into a vein or muscle</p><p><strong>Bone and joint infections, and heart infections</strong></p><p>&bull;&nbsp;&nbsp; Starting dose (for the first three to five doses): 12 mg for every kilogram of body weight, given every 12 hours, by injection into a vein</p><p>&bull;&nbsp;&nbsp; Maintenance dose: 12 mg for every kilogram of body weight, given once a day, by injection into a vein or muscle.</p><p><strong>Infection caused by &lsquo;Clostridium difficile&rsquo; bacteria</strong></p><p>The recommended dose is 100 to 200 mg by mouth, twice a day for 7 to 14 days.</p><p><strong>Adults and elderly patients with kidney problems</strong></p><p>If you have kidney problems, your dose will usually need to be lowered after the fourth day of treatment:</p><p>&bull;&nbsp;&nbsp; For people with mild and moderate kidney problems - the maintenance dose will be given every two days, or half of the maintenance dose will be given once a day.</p><p>&bull;&nbsp;&nbsp; For people with severe kidney problems or on Hemodialysis - the maintenance dose will be given every three days, or one-third of the maintenance dose will be given once a day.</p><p>Peritonitis for patients on peritoneal dialysis</p><p>The starting dose is 6 mg for every kilogram of body weight, as a single injection into a vein, followed by:</p><p>&bull;&nbsp;&nbsp;&nbsp; Week one: 20 mg/L in each dialysis bag</p><p>&bull;&nbsp;&nbsp;&nbsp; Week two: 20 mg/L in every other dialysis bag</p><p>&bull;&nbsp;&nbsp;&nbsp; Week three: 20 mg/L in the overnight dialysis bag.</p><p><strong>Babies (from birth to the age of 2 months)</strong></p><p>&bull;&nbsp;&nbsp;&nbsp; Starting dose (on the first day): 16 mg for every kilogram of body weight, as an infusion through a drip into a vein.</p><p>&bull;&nbsp;&nbsp;&nbsp; Maintenance dose: 8 mg for every kilogram of body weight, given once a day, as an infusion through a drip into a vein.</p><p><strong>Children (from 2 months to 12 years)</strong></p><p>&bull;&nbsp;&nbsp; Starting dose (for the first three doses): 10 mg for every kilogram of body weight, given every 12 hours, by injection into a vein.</p><p>&bull;&nbsp;&nbsp; Maintenance dose: 6 to 10 mg for every kilogram of body weight, given once a day, by injection into a vein.</p><p>How Ticopex<sup>&reg;</sup> is given</p><p>The medicine will normally be given to you by a doctor or nurse.</p><p>&bull; It will be given by injection into a vein (intravenous use) or muscle (intramuscular use).</p><p>&bull; It can also be given as a infusion through a drip into a vein.</p><p>Only the infusion should be given in babies from birth to the age of 2 months.</p><p>To treat certain infections, the solution may be taken by mouth (oral use).</p><p><strong>If you have more Ticopex</strong> <strong><sup>&reg;</sup> than you should</strong></p><p>It is unlikely that your doctor or nurse will give you too much medicine. However, if you think you have been given too much <strong>Ticopex<sup>&reg;</sup></strong> or if you are agitated, talk to your doctor or nurse straight away.</p><p><strong>If you forget to have Ticopex</strong> <strong><sup>&reg;</sup></strong></p><p>Your doctor or nurse will have instructions about when to give you Ticopex. It is unlikely that they will not give you the medicine as prescribed. However, if you are worried, talk to your doctor or nurse.</p><p><strong>If you stop having Ticopex</strong> <strong><sup>&reg;</sup></strong></p><p>Do not stop having this medicine without first talking to your doctor, pharmacist or nurse.</p><p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Serious side effects</strong></p><p><strong>Stop your treatment and tell your doctor or nurse straight away, if you notice any of the following serious side effects - you may need urgent medical treatment:</strong></p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&bull;&nbsp;&nbsp;&nbsp; sudden life-threatening allergic reaction - the signs may include: difficulty in breathing or wheezing, swelling, rash, itching, fever, chills</p><p><strong>Rare </strong>(may affect up to 1 in 1000 people)</p><p>&bull;&nbsp;&nbsp;&nbsp; flushing of the upper body</p><p><strong>Not known </strong>(frequency cannot be estimated from the available data)</p><p>&bull;&nbsp;&nbsp;&nbsp; blistering of the skin, mouth, eyes or genitals - these may be signs of something called &lsquo;toxic epidermal necrolysis&rsquo; or &lsquo;Stevens-Johnson syndrome&rsquo; or &lsquo;drug reaction with eosinophilia and systemic symptoms (DRESS)&rsquo;. DRESS appears initially as flu-like symptoms and a rash on the face then an extended rash with a high temperature, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes.</p><p>Tell your doctor or nurse straight away, if you notice any of the side effects above.</p><p><strong>Tell your doctor or nurse straight away, if you notice any of the following serious side effects - you may need urgent medical treatment:</strong></p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&bull;&nbsp;&nbsp;&nbsp; swelling and clotting in a vein</p><p>&bull;&nbsp;&nbsp;&nbsp; difficulty in breathing or wheezing (bronchospasm)</p><p>&bull;&nbsp;&nbsp;&nbsp; getting more infections than usual - these could be signs of a decrease in your blood cell count</p><p><strong>Not known </strong>(frequency cannot be estimated from the available data)</p><p>&bull;&nbsp;&nbsp;&nbsp; lack of white blood cells - the signs may include: fever, severe chills, sore throat or mouth ulcers (agranulocytosis)</p><p>&bull;&nbsp;&nbsp;&nbsp; kidney problems or changes in the way your kidneys work - shown in tests</p><p>&bull;&nbsp;&nbsp;&nbsp; epileptic fits</p><p>Tell your doctor or nurse straight away, if you notice any of the side effects above.</p><p>Other side effects</p><p>Talk to your doctor, pharmacist or nurse if you get any of these:</p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&bull;&nbsp;&nbsp;&nbsp; Rash, erythema, pruritus</p><p>&bull;&nbsp;&nbsp;&nbsp; Pain</p><p>&bull;&nbsp;&nbsp;&nbsp; Fever</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&bull;&nbsp;&nbsp;&nbsp; decrease in platelet count.</p><p>&bull;&nbsp;&nbsp;&nbsp; raised blood levels of liver enzymes</p><p>&bull;&nbsp;&nbsp;&nbsp; raised in blood levels of creatinine (to monitor your kidney)</p><p>&bull;&nbsp;&nbsp;&nbsp; hearing loss, ringing in the ears or a feeling that you, or things around you are moving</p><p>&bull;&nbsp;&nbsp;&nbsp; feeling or being sick (vomiting), diarrhoea</p><p>&bull;&nbsp;&nbsp;&nbsp; feeling dizzy or headache</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>&bull;&nbsp;&nbsp;&nbsp; infection (abscess).</p><p><strong>Not known </strong>(frequency cannot be estimated from the available data)</p><p>&bull;&nbsp;&nbsp;&nbsp; problems where the injection was given - such as reddening of the skin, pain or swelling</p><p><strong>Reporting of side effects</strong></p><p><strong>-The National Pharmacovigilance and Drug Safety Centre (NPC):</strong></p><p>&bull; Fax: +966-11-205-7662</p><p>&bull; SFDA Call Center: 19999</p><p>&bull; E-mail: npc.drug@sfda.gov.sa</p><p>&bull; Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and label of the vial after EXP. The expiry date refers to the last day of that month.</p><p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What <strong>Ticopex<sup>&reg;</sup> </strong>contains</p><p>&bull;&nbsp;&nbsp;&nbsp; The active substance is teicoplanin. Each vial contains 200 mg of Teicoplanin.</p><p>&bull;&nbsp;&nbsp;&nbsp; The other ingredients are sodium chloride and sodium hydroxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Ticopex® is a powder for solution for injection
The powder is white to off-white cake powder.
Pack size:
- 1 vial 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>MS Pharma Saudi - Riyadh-kingdom of Saudi Arabia</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                04/2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">دواء تايكوبيكس(م) هو مضاد حيوي. يحتوي على دواء يسمى &quot;تيكوبلانين&quot;. وهو يعمل عن طريق قتل البكتريا التي تسبب العدوى في الجسم.</p><p dir="RTL">يستخدم دواء تايكوبيكس(م) في البالغين والأطفال (بما في ذلك الأطفال حديثي الولادة) لعلاج الالتهابات البكتررية في:</p><p dir="RTL">- الجلد وتحت الجلد -تسمى أحيانا &quot;الأنسجة الرخوة&quot;</p><p dir="RTL">- العظام والمفاصل</p><p dir="RTL">- الرئة</p><p dir="RTL">- المسالك البولية</p><p dir="RTL">- القلب -يطلق عليه أحيانًا &quot;التهاب الشغاف&quot;</p><p dir="RTL">- جدار البطن -التهاب الصفاق</p><p dir="RTL">- الدم، عندما يحدث بسبب اي من الحالات المذكورة أعلاه</p><p dir="RTL">يمكن استعمال دواء تايكوببكس (م) لعلاج بعض أنواع العدوى التي تسببها بكتريا &quot;كلوستريديوم ديفيسيل&quot; في الأمعاء الغليظة. لهذا يتم تناول المحلول عن طريق الفم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تستعمل دواء تايكوبيكس(م) إذا كان لديك:</p><p dir="RTL">&bull; حساسية تجاه تيكوبلانين أو أي من المكونات الأخرى لهذا الدواء (المذكورة في القسم ٦).</p><p dir="RTL">المحاذير والاحتياطات</p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي أو الممرضة قبل أن يتم إعطاءك دواء تايكوبيكس(م) في حال أن:</p><p dir="RTL">&bull; لديك حساسية تجاه مضاد حيوي يسمى فانكومايسين</p><p dir="RTL">&bull; لديك بَيغ في الجزء العلوي من جسمك (متلازمة الرجل الأحمر)</p><p dir="RTL">&bull; لديك نقص في عدد الصفائح الدموية (نقص الصفيحات)</p><p dir="RTL">&nbsp;&bull; لديك مشاكل في الكلى</p><p dir="RTL">&bull; إذا كنت تتناول أدوية أخرى قد تسبب مشاكل في السمع و/أو مشاكل في الكلى. قد يلزمك إجراء اختبارات منتظمة لمعرفة ما إذا كانت لديك الكلى و/أوالكبد تعمل بشكل سليم (انظر &quot;تناول الأدوية الأخرى ودواء تايكوبيكس(م)&quot;).</p><p dir="RTL">إذا كان أي من الحالات المذكورة أعلاه ينطبق عليك (أو أنك لست متأكدا من ذلك)، تحدث إلى طبيبك أو الصيدلي أو الممرضة قبل أن يتم إعطاءك دواء تايكوبيكسس (م).</p><p dir="RTL">الاختبارات</p><p dir="RTL">خلال فترة العلاج، قد يتم إخضاعك لاختبارات فحص الدم والكليتين و/أو السمع. ويكون هذا أكثر احتمالا في حال أنك:</p><p dir="RTL">&bull; ستستمر علاجاتك لفترة طويلة</p><p dir="RTL">&bull; لديك مشكلة في الكلى</p><p dir="RTL">&bull; إذا كنت تتناول أو قد تتناول أدوية أخرى قد توثر على الجهاز العصبي أو الكليتين أو السمع. في الأشخاص الذين يتم إعطاؤهم دواء تايكوبيكس(م) لفترة طويلة، قد تنمو البكتيريا التي لا تتأثر بالمضاد الحيوي أكثر من المعتاد -وسيتحقق طبيبك من ذلك.</p><p dir="RTL">تناول الأدوية الأخرى ودواء تايكوبيكس(م)</p><p dir="RTL">أخبر طبيبك أو الصيدلي أو الممرضة إذا كنت تستعمل واستعملت أو يمكن أن تستعمل أي أدوية أخرى مؤخرًا. هذا لأن دواء تايكوبيكس(م) يمكن أن يؤثر على طريقة عمل بعض الأدوية الأخرى وأيضا يمكن لبعض الأدوية أن تؤثر على طريقة عمل دواء تايكوبيكس(م). وعلى وجه الخصوص، أخبر طبيبك أو الصيدلي أو الممرضة إذا كنت تتناول أي من الأدوية التالية:</p><p dir="RTL">&nbsp;&bull; أمينوجليكوسيدات، لأنها لا يجب أن تخلط جنبا إلى جنب مع دواء تايكوبيكس(م) في نفس الحقنة. وقد تسبب أيضًا مشاكل في السمع و/أو مشاكل في الكلى.</p><p dir="RTL">&bull; امفوتريسين بي -وهو دواء يعالج الالتهابات الفطرية التي قد تسبب مشاكل في السمع و/أو مشاكل في الكلى</p><p dir="RTL">&bull; سايكلوسبورين -دواء يوثر على جهاز المناعة وقد يسبب مشاكل في السمع و/أو مشاكل في الكلى</p><p dir="RTL">&bull; سيسبلاتين -دواء يعالج الأورام الخبيثة وقد يسبب مشاكل في السمع و/أو مشاكل في الكلى</p><p dir="RTL">&bull; أقراص الماء (مثل الفوروسيميد) -وتسمى أيضًا &quot;مدرات البول&quot; التي قد تسبب مشاكل في السمع و/أو مشاكل في الكلى.</p><p dir="RTL">&nbsp;إذا كان أي من الحالات المذكورة أعلاه يتطبق عليك (أو أنك لست متأكدا من ذلك) تحدث مع طبيبك أو الصيدلي أو الممرضة قبل أن يتم إعطاؤك دواء تايكوبيكس(م)</p><p dir="RTL">الحمل والرضاعة الطبيعية والخصوبة</p><p dir="RTL">إذا كنت حاملاً أو تعتقدي أنك حامل أو أنك تخططين لإنجاب طفل، فعليك سؤال طبيبك أو الصيدلي للحصول على المشورة قبل استعمال هذا الدواء. وسوف يقررون ما إذا كان من الممكن أو من غير الممكن إعطاءك هذا الدواء أثناء الحمل. وقد يكون هناك خطر محتمل على الأذن الداخلية ومشاكل في الكلى.</p><p dir="RTL">أخبري طبيبك إذا كنت تقومي بالإرضاع الطبيعي وذلك قبل إعطاءك هذا الدواء. وسوف يقرر الطبيب ما إذا كان بإمكانك الاستمرار في الإرضاع الطبيعي أم لا بينما يتم إعطاءك دواء تايكوبيكس(م).</p><p dir="RTL">لم تقدم الدراسات بخصوص التكاثر الحيواني أدلة على وجود مشكلات في الخصوبة.</p><p dir="RTL">القيادة واستعمال الآلات</p><p dir="RTL">قد تصاب بالصداع أو تشعر بالدوار أثناء علاجك بدواء تايكوبيكس(م). وإذا حدث لك ذلك، فلا تمارس قيادة المركبات أو تستعمل أي أدوات أو آلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الجرعة الموصي بها هي:</p><p dir="RTL">للبالغين والأطفال (12 سنة فأكثر) الذين ليس لديهم مشاكل في الكلى</p><p dir="RTL">الجلد والأنسجة الرخوة والرئة والتهابات المسالك البولية</p><p dir="RTL">&bull; جرعة البدء (بالنسبة للجرعات الثلاث الأولى):٦ ملغم لكل كيلوغرام من وزن الجسم، تعطى كل 12 ساعة، عن طريق الحقن في الوريد او العضل</p><p dir="RTL">&bull; جرعة المداومة: ٦ ملغم لكل كيلوغرام من وزن الجسم، تعطى مرة واحدة في اليوم، عن طريق الحقن في الوريد أوالعضل</p><p dir="RTL">إصابات العظام والمفاصل، والالتهابات القلبية</p><p dir="RTL">&bull; جرعة البدء (بالنسبة لأول ثلاث إلى خمس جرعات): 12 ملغم لكل كيلوغرام من وزن الجسم، تعطى كل 12 ساعة، عن طريق الحقن في الوريد</p><p dir="RTL">&bull; جرعة المداومة: 12 ملغم لكل كيلوغرام من ورن الجسم، تعطى مرة واحدة في اليوم، عن طريق الحقن في الوريد أو العضل</p><p dir="RTL">العدوى التي تسببها البكتيريا &ldquo;الكلوستريديوم ديفيسيل&quot;</p><p dir="RTL">الجرعة الموصي بها هي 100 إلى 200 ملغم عن طريق الفم، مرتين في اليوم لمدة 7 إلى 14 يومًا.</p><p dir="RTL">الكبار والمرضى المسنين الذين لديهم مشاكل في الكلى</p><p dir="RTL">إذا كنت تعاني من مشاكل في الكلى، فعادة ما تحتاج إلى تخفيض الجرعة بعد اليوم الرابع من العلاج:</p><p dir="RTL">&bull; بالنسبة للأشخاص الذين يعانون من مشاكل خفيفة أو متوسطة الشدة في الكلى -سيتم إعطاءهم جرعة المداومة كل يومين أو سيتم اعطاءهم نصف جرعة المداومة مرة واحدة في اليوم.</p><p dir="RTL">&bull; بالنسبة للأشخاص الذين يعانون من مشاكل شديدة في الكلى أو غسيل كلى -سيتم إعطاءهم جرعة المداومة كل ثلاثة أيام أو سيتم إعطاءهم ثلث جرعة المداومة مرة واحدة في اليوم.</p><p dir="RTL">التهاب الصفاق للمرضى الذين يخضعون لغسيل الكلى البريتوني</p><p dir="RTL">جرعة البدء هي ٦ ملغم لكل كيلوغرام من وزن الجسم، كحقن واحد في الوريد، يليها:</p><p dir="RTL">&bull; الأسبوع الأول: 20 ملغم/لتر في كل كيس غسيل كلوي</p><p dir="RTL">&bull; الأسبوع الثاني: 20 ملغم/لتر في كل كيس غسيل كلوي</p><p dir="RTL">&bull; الأسبوع الثالث: 20 ملغم/لتر في كيس غسيل الكلى الليلي.</p><p dir="RTL">الأطفال (من الولادة وحتى عمر شهرين)</p><p dir="RTL">&bull; جرعة البدء (في اليوم الأول): 16 ملغم لكل كيلوغرام من ورن الجسم، كتسريب عن طريق الحقن في الوريد.</p><p>&bull; جرعة المداومة: 8 ملغم لكل كيلوغرام من وزن الجسم، تعطى مرة واحدة في اليوم، كتسريب عن طريق الحقن في الوريد.</p><p dir="RTL">الأطفال (من شهرين إلى 12 عامًا)</p><p dir="RTL">&bull; جرعة البدء (للجرعات الثلاث الأولى): 10 ملغم لكل كيلوغرام من وزن الجسم، تعطى كل 12 ساعة، عن طريق الحقن في الوريد.</p><p dir="RTL">&bull; جرعة المداومة: 6 إلى 10 ملغم لكل كيلوغرام من وزن الجسم، تعطى مرة واحدة في اليوم، عن طريق الحقن في الوريد.</p><p dir="RTL">كيف يتم إعطاء دواء تايكوبيكس(م)</p><p dir="RTL">عادة ما تعطى لك الجرعة من تايكوبيكس(م) من قبل الطبيب أوالممرضة.</p><p dir="RTL">&bull; سيتم إعطاء الجرعة عن طريق الحقن في الوريد (استعمال الوريدي) أو في العضل (استعمال عضلي).</p><p dir="RTL">&bull; يمكن إعطاء دواء تايكوبيكس (م) أيضا عبر التسريب في الوريد.</p><p dir="RTL">تستعمل طريقة التسريب في الوريد فقط عند إعطاء الدواء للرضع من عمر الولادة إلى عمر شهرين.</p><p dir="RTL">لعلاج بعض أنواع العدوى، يمكن تناول المحلول عن طريق الفم (عن طريق الفم).</p><p dir="RTL">إذا تم إعطاءك جرعة من دواء تايكوبيكس(م) أكثر مما يجب</p><p dir="RTL">من غير المحتمل أن يعطيك طبيبك أو ممرضتك جرعة من الدواء أكثر مما يجب. ومع ذلك، أذا كتت تعتقد أنك قد أعطيت الكثير من دواء تايكوبيكس(م) أو إذا كنت مضطربًا تحدث إلى طبيبك أو الممرضة على الفور.</p><p dir="RTL">إذا كنت قد نسيت وفاتك أخذ جرعة من دواء تايكوبيكس(م)</p><p dir="RTL">سيكون لدى الطبيب أو الممرضة تعليمات حول موعد إعطائك دواء تايكوبيكس(م). ومن غيرالمحتمل أن لا يعطوك الدواء كما هو مقرر. ومع ذلك، إذا كنت قلقا بهذا الخصوص تحدث إلى طبيبك أو الممرضة.</p><p dir="RTL">إذا توقفت عن تناول دواء تايكوبيكس(م)</p><p dir="RTL">لا تتوقف عن تناول هذا الدواء دون التحدث إلى طبيبك أو الصيدلي أو الممرضة.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استعمال هذا الدواء اسأل طبيبك أو الصيدلي أو الممرضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يسبب دواء اكسيناميكس للحقن آثارًا جانبية، على الرغم من عدم حصول ذلك لجميع من يتناوله.</p><p dir="RTL">آثار جانبية خطيرة</p><p dir="RTL">أوقف العلاج وأخبر طبيبك أو المرضة على الفور، إذا لاحظت أيًا من الآثار الجانبية الخطيرة التالية &ndash; فقد تحتاج إلى علاج طبي عاجل:</p><p dir="RTL">غيرشائعة (قد تؤثر على شخص واحد من بين كل 100 شخص)</p><p dir="RTL">&bull; تفاعل تحسسي مفاجئ يهدد الحياة -قد يشمل علامات مثل: صعوبة في التنفس أو أزيز، تورم، طفح جلدي، حكة، حمى، قشعريرة</p><p dir="RTL">نادرة (قد توثر على 1 من كل 1000 شخص)</p><p dir="RTL">&bull; احمرار الجزء العلوي من الجسم</p><p dir="RTL">غير معروفة (لا بكن تقدير تكرارها من البيانات المتاحة)</p><p dir="RTL">&bull; تقرحات في الجلد أو الفم أو العينين أو الأعضاء التناسلية &ndash;وقد تكون هذه علامات على شيء يسمى &quot;انحلال البشرة النخاعي السمي&quot; أو&quot;متلازمة ستيفنز جونسون&quot; أو&quot;التفاعل الدوائي مع فرط الحمضات والأعراض الجهازية&quot;. يظهر التفاعل الدوائي مع فرط الحمضات والأعراض الجهازية في البداية كأعراض تشبه أعراض الأنفلونزا وطفح على الوجه ثم طفح جلدي ممتد مع ارتفاع في درجة الحرارة، وزيادة في مستويات إنزيمات الكبد في اختبارات الدم وزيادة في نوع من خلايا الدم البيضاء (فرط الحمضات) وتضخم الغدد الليمفاوية.</p><p dir="RTL">أخبر طبيبك أو الممرضة على الفور إذا لاحظت أيًا من الأعراض الجانبية المذكورة أعلاه.</p><p dir="RTL">أخبر طبيبك أو الممرضة على الفور إذا لاحظت أيًا من الآثار الجانبية الخطيرة التالية &ndash; فقد تحتاج إلى علاج طبي عاجل:</p><p dir="RTL">غيرشائعة (قد توثر على شخص واحد من بين كل 100 شخص)</p><p dir="RTL">&bull; تورم وتخثر في الوريد</p><p dir="RTL">&bull; صعوبة في التنفس أو صفير عند التنفس (تشنج قصبي)</p><p dir="RTL">&bull; حصول مزيد من العدوى أكثر من المعتاد -فقد تكون هذه علامات انخفاض في عدد خلايا الدم لديك</p><p dir="RTL">غير معروفة (لا يمكن تقدير تكرارها من البيانات المتاحة)</p><p dir="RTL">&bull; نقص خلايا الدم البيضاء -قد تشمل علامات مثل: حمى، قشعريرة شديدة، التهاب الحلق أوقروح الفم (ندرة المحببات)</p><p dir="RTL">&bull; مشاكل في الكلى أو تغيرات في طريقة عمل الكلى &ndash;تظهر في الاختبارات</p><p dir="RTL">&bull; نوبات صرع</p><p dir="RTL">أخبر طبيبك أو ممرضتك على الفور، إذا لاحظت أيًا من الأعراض الجانبية المذكورة أعلاه.</p><p dir="RTL">آثار جانبية أخرى</p><p dir="RTL">&bull; تحدث مع طبيبك أو الصيدلي أو الممرضة إذا حصلت لك أي من الأعراض التالية:</p><p dir="RTL">حالة شائعة (قد توثر على شخص واحد من كل 10 أشخاص)</p><p dir="RTL">&bull; طفح، حمامي، حكة</p><p dir="RTL">&bull; ألم</p><p dir="RTL">&bull; حمة</p><p dir="RTL">غير شائعة (قد توثر على شخهى واحد من بين كل 100 شخص)</p><p dir="RTL">&bull; انخفاض في عدد الصفائح الدموية.</p><p dir="RTL">&bull; ارتفاع مستويات إنزيمات الكبد في الدم</p><p dir="RTL">&bull; ارتفاع في مستويات الكرياتينين في الدم (لرصد الكلى)</p><p dir="RTL">&bull; فقدان السمع أو الطنين في الأذنين أو الشعور بأنك أو الأشياء المحيطة بك تتحرك</p><p dir="RTL">&bull; المرض أو الشعور بالمرض (تقيؤ)، إسمال</p><p dir="RTL">&bull; الشعور بالدوار أو الصداع</p><p dir="RTL">نادرة (قد توثر على 1 من كل 100 شخص)</p><p dir="RTL">&bull; إصابة (خراج).</p><p dir="RTL">غير معروفة (لا يمكن تقدير تكرارها من البيانات المتاحة)</p><p dir="RTL">&bull; مشاكل عند إعطاء الحقن -مثل احمرار الجلد أو الألم أو التورم</p><p dir="RTL">الإبلاغ عن الآثار الجانبية</p><p dir="RTL">المركز الوطني للتيقظ والسلامة الدوائية:</p><p dir="RTL">&bull; فاكس: ٧٦٦٢-٢٠٥-١١-٩٦٦+</p><p dir="RTL">&bull; &bull;رقم الاتصال المجاني: 19999</p><p dir="RTL">&bull; البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&bull; الموقع الالكتروني: https://ade.sfda.gov.sa</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احتفظ بهذا الدواء بعيدا عن متناول الأطفال.</p><p dir="RTL">لا تستعمل هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على الكرتون وعلى اللاصقة على القارورة. ويشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">يحفظ عند درجة حرارة لا تتجاوز 30 درجة مئوية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مكونات دواء تايكوبيكس(م)؟</p><p dir="RTL">&bull; المادة الفعالة هي تيكوبلانين. كل عبوة تحتوي على 200 ملغم.</p><p dir="RTL">&bull; المكونات الأخرى هي كلوريد الصوديوم وهيدروكسيد الصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تايكوبيكس(م) عبارة عن بودرة جاهزة للحل لأغراض الحقن.</p><p dir="RTL">هي عبارة عن بودرة بيضاء الى ابيض فاتح.</p><p dir="RTL">حجم العبوة:</p><p dir="RTL">-عبوة واحدة</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك رخصة التسويق<br />ام اس فارما السعودية -</strong><strong>الرياض </strong><strong>&ndash;</strong><strong> المملكة العربية السعودية</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            04/2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ticopex® (200mg/vial) Powder for solution for injection,
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Material name Quantity
Used/ Vial
Teicoplanin 200.0mg
Sodium Chloride 63.06 mg
Sodium hydroxide QS
Water for Injection* QS to 3 ml
Total Volume 3 ml (Before lyophilisation)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for solution for injection
White to off-white cake powder
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TICOPEX is indicated in adults and in children from birth for the parenteral treatment of the<br />following infections (see sections 4.2, 4.4 and 5.1):<br />&bull; complicated skin and soft tissue infections,<br />&bull; bone and joint infections,<br />&bull; hospital acquired pneumonia,<br />&bull; community acquired pneumonia,<br />&bull; complicated urinary tract infections,<br />&bull; infective endocarditis,<br />&bull; peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD),<br />&bull; Bacteremia that occurs in association with any of the indications listed above.<br />Ticopex is also indicated as an alternative oral treatment for Clostridium difficile infection-associated<br />diarrhea and colitis.<br />Where appropriate, Teicoplanin should be administered in combination with other antibacterial<br />agents. Consideration should be given to official guidance on the appropriate use of antibacterial<br />agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />The dose and duration of treatment should be adjusted according to the underlying type and severity of<br />infection and clinical response of the patient, and patient factors such as age and renal function.<br />Summary of product characteristics<br />Ticopex&reg; (200mg/vial)<br />Powder for solution for injection<br />Measurement of serum concentrations<br />Teicoplanin trough serum concentrations should be monitored at steady state after completion of the loading<br />dose regimen in order to ensure that a minimum trough serum concentration has been reached:<br />&bull; For most Gram-positive infections, teicoplanin trough levels of at least 10 mg/L when measured by High<br />Performance Liquid Chromatography (HPLC), or at least 15 mg/L when measured by Fluorescence<br />Polarization Immunoassay (FPIA) method.<br />&bull; For endocarditis and other severe infections, teicoplanin trough levels of 15-30 mg/L when measured by<br />HPLC, or 30-40 mg/L when measured by FPIA method.<br />During maintenance treatment, teicoplanin trough serum concentrations monitoring may be performed at<br />least once a week to ensure that these concentrations are stable.<br />Adults and elderly patients with normal renal function</p><p>The dose is to be adjusted on bodyweight whatever the weight of the patient.&nbsp;<br />Duration of treatment&nbsp;<br />The duration of treatment should be decided based on the clinical response. For infective endocarditis a minimum of 21 days is usually considered appropriate. Treatment should not exceed 4 months.&nbsp;<br />Combination therapy&nbsp;<br />Teicoplanin has a limited spectrum of antibacterial activity (Gram positive). It is not suitable for use as a single agent for the treatment of some types of infections unless the pathogen is already documented and known to be susceptible or there is a high suspicion that the most likely pathogen(s) would be suitable for treatment with teicoplanin.&nbsp;</p><p>Clostridium difficile infection-associated diarrhoea and colitis<br />The recommended dose is 100-200 mg administered orally twice a day for 7 to 14 days.<br />Elderly population<br />No dose adjustment is required, unless there is renal impairment (see below).<br />Adults and elderly patients with impaired renal function<br />Dose adjustment is not required until the fourth day of treatment, at which time dosing should be adjusted to<br />maintain a serum trough concentration of at least 10 mg/L when measured by HPLC, or at least 15 mg/L<br />when measured by FPIA method.<br />After the fourth day of treatment:<br />&bull; In mild and moderate renal insufficiency (creatinine clearance 30-80 mL/min): maintenance dose should be<br />halved, either by administering the dose every two days or by administering half of this dose once a day.<br />&bull; In severe renal insufficiency (creatinine clearance less than 30 mL/min) and in haemodialysed patients: dose<br />should be one-third the usual dose, either by administering the initial unit dose every third day or by<br />administering one-third of this dose once a day.<br />Teicoplanin is not removed by hemodialysis.<br />Patients in continuous ambulatory peritoneal dialysis (CAPD)<br />After a single intravenous loading dose of 6 mg/kg bodyweight, 20 mg/L is administered in the bag of the<br />dialysis solution in the first week, 20 mg/L in different bags the second week and then 20 mg/L in the<br />overnight bag in the third week.<br />Paediatric population<br />The dose recommendations are the same in adults and children above 12 years of age.<br />Neonates and infants up to the age of 2 months:<br />Loading dose<br />One single dose of 16 mg/kg body weight, administered intravenously by infusion on the first day.<br />Maintenance dose<br />One single dose of 8 mg/kg body weight administered intravenously by infusion once a day.<br />Children (2 months to 12 years):<br />Loading dose<br />One single dose of 10 mg/kg body weight administered intravenously every 12 hours, repeated 3 times.<br />Maintenance dose<br />One single dose of 6-10 mg/kg body weight administered intravenously once a day.<br />Method of administration<br />Teicoplanin should be administered by the intravenous or intramuscular route. The intravenous injection may<br />be administered either as a bolus over 3 to 5 minutes or as a 30-minute infusion.<br />Only the infusion method should be used in neonates.<br />For Clostridium difficile infection-associated diarrhoea and colitis, the oral route is to be used.<br />For instructions on reconstitution and dilution of the medicinal product before administration, see section 6.6.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to teicoplanin or to any of the excipients listed in section 6.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypersensitivity reactions<br />Serious, life-threatening hypersensitivity reactions, sometimes fatal, have been reported with<br />teicoplanin (e.g. anaphylactic shock). If an allergic reaction to teicoplanin occurs, treatment should<br />be discontinued immediately and appropriate emergency measures should be initiated.<br />Teicoplanin must be administered with caution in patients with known hypersensitivity to<br />vancomycin, as crossed hypersensitivity reactions, including fatal anaphylactic shock, may occur.<br />However, a prior history of &quot;red man syndrome&quot; with vancomycin is not a contraindication to the use<br />of teicoplanin.<br />Infusion related reactions<br />In rare cases (even at the first dose), red man syndrome (a complex of symptoms including pruritus,<br />urticaria, erythema, angioneurotic oedema, tachycardia, hypotension, dyspnoea) has been observed.<br />Stopping or slowing the infusion may result in cessation of these reactions. Infusion related reactions<br />can be limited if the daily dose is not given via bolus injection but infused over a 30-minute period<br />Severe bullous reactions<br />Life-threatening or even fatal cutaneous reactions Stevens-Johnson syndrome (SJS) and Toxic<br />Epidermal Necrolysis (TEN) have been reported with the use of teicoplanin. If symptoms or signs of<br />SJS or TEN (e.g. progressive skin rash often with blisters or mucosal lesions) are present teicoplanin<br />treatment should be discontinued immediately.<br />Spectrum of antibacterial activity<br />Teicoplanin has a limited spectrum of antibacterial activity (Gram-positive). It is not suitable for use<br />as a single agent for the treatment of some types of infections unless the pathogen is already<br />documented and known to be susceptible or there is a high suspicion that the most likely pathogen(s)<br />would be suitable for treatment with teicoplanin.<br />The rational use of teicoplanin should take into account the bacterial spectrum of activity, the safety<br />profile and the suitability of standard antibacterial therapy to treat the individual patient. On this<br />basis it is expected that in most instances teicoplanin will be used to treat severe infections in patients<br />for whom standard antibacterial activity is considered to be unsuitable<br />Loading dose regimen<br />Since data on safety are limited, patients should be carefully monitored for adverse reactions when<br />teicoplanin doses of 12mg/kg body weight twice a day are administered. Under this regimen blood<br />creatinine values should be monitored in addition to the recommended periodic haematological<br />examination.<br />Teicoplanin should not be administered by intraventricular use.</p><p><br />Thrombocytopenia<br />Thrombocytopenia has been reported with teicoplanin. Periodic haematological examinations are<br />recommended during treatment, including complete cell blood count.<br />Nephrotoxicity<br />Renal failure has been reported in patients treated with teicoplanin (see section 4.8). Patients with<br />renal insufficiency, and/or in those receiving teicoplanin in conjunction with or sequentially with<br />other medicinal products with known nephrotoxic potential (aminoglycosides, colistin, amphotericin<br />B, ciclosporin, and cisplatin) should be carefully monitored, and should include auditory tests.<br />Since teicoplanin is mainly excreted by the kidney, the dose of teicoplanin must be adapted in<br />patients with renal impairment (see section 4.2).<br />Ototoxicity<br />As with other glycopeptides, ototoxicity (deafness and tinnitus) has been reported in patients treated<br />with teicoplanin (see section 4.8). Patients who develop signs and symptoms of impaired hearing or<br />disorders of the inner ear during treatment with teicoplanin should be carefully evaluated and<br />monitored, especially in case of prolonged treatment and in patients with renal insufficiency. Patients<br />receiving teicoplanin in conjunction with or sequentially with other medicinal products with known<br />neurotoxic/ototoxic potential (aminoglycosides, ciclosporin, cisplatin, furosemide and ethacrynic<br />acid) should be carefully monitored and the benefit of teicoplanin evaluated if hearing deteriorates.<br />Special precautions must be taken when administering teicoplanin in patients who require<br />concomitant treatment with ototoxic and/or nephrotoxic medicinal products for which it is<br />recommended that regular haematology, liver and kidney function tests are carried out.<br />Superinfection<br />As with other antibiotics, the use of teicoplanin, especially if prolonged, may result in overgrowth of<br />non-susceptible organisms. If superinfection occurs during therapy, appropriate measures should be<br />taken.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><br />No specific interaction studies have been performed.<br />Teicoplanin and aminoglycoside solutions are incompatible and must not be mixed for injection;<br />however, they are compatible in dialysis fluid and may be freely used in the treatment of CAPDrelated<br />peritonitis. Teicoplanin should be used with care in conjunction with or sequentially with<br />other medicinal products with known nephrotoxic or ototoxic potential. These include<br />aminoglycosides, colistin, amphotericin B, ciclosporin, cisplatin, furosemide, and ethacrynic<br />acid (see section 4.4). However, there is no evidence of synergistic toxicity in combinations with<br />teicoplanin.<br />In clinical studies, teicoplanin has been administered to many patients already receiving various<br />medications including other antibiotics, antihypertensives, anaesthetic agents, cardiac medicinal<br />products and antidiabetic agents without evidence of adverse interaction.<br />Paediatric population</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />There are a limited amount of data from the use of teicoplanin in pregnant women. Studies in animals<br />have shown reproductive toxicity at high doses (see section 5.3): in rats, there was an increased<br />incidence of stillbirths and neonatal mortality. The potential risk for humans is unknown.<br />Therefore, teicoplanin should not be used during pregnancy unless clearly necessary. A potential risk<br />of inner ear and renal damage to the foetus cannot be excluded (see section 4.4).<br />Breast-feeding<br />It is unknown whether teicoplanin is excreted in human milk. There is no information on the<br />excretion of teicoplanin in animal milk. A decision on whether to continue/discontinue breast-feeding<br />or to continue/discontinue therapy with teicoplanin should be made taking into account the benefit of<br />breast-feeding to the child and the benefit of teicoplanin therapy to the mother.<br />Fertility<br />Animal reproduction studies have not shown evidence of impairment of fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TICOPEX has minor influence on the ability to drive and use machines. Teicoplanin can cause<br />dizziness and headache. The ability to drive or use machines may be affected. Patients experiencing<br />these undesirable effects should not drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Like all medicines, TICOPEX can cause side effects, although not all patients have them.<br />Tabulated list of adverse reactions<br />In the table below all the adverse reactions, which occurred at an incidence greater than placebo and<br />more than one patient are listed using the following convention:<br />Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare<br />(&ge;1/10,000 to &lt;1/1,000);very rare (&lt;1/10,000); not known (cannot be estimated from the available<br />data).<br />Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.<br />Adverse reactions should be monitored when teicoplanin doses of 12 mg/kg body weight twice a day<br />are administered(see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms<br />Cases of accidental administration of excessive doses to pediatric patients have been reported. In one<br />case agitation occurred in a 29-day-old newborn who had been administered 400 mg intravenously<br />(95 mg/kg).<br />Management<br />Treatment of teicoplanin overdose should be symptomatic.<br />Teicoplanin is not removed by hemodialysis and only slowly by peritoneal dialysis</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Glycopeptide Antibacterials,<br />ATC code: J01XA 02<br />Mechanism of action<br />Teicoplanin inhibits the growth of susceptible organisms by interfering with cell-wall biosynthesis at a site<br />different from that affected by beta-lactams. Peptidoglycan synthesis is blocked by specific binding to Dalanyl-<br />D-alanine residues.<br />Mechanism of resistance<br />Resistance to teicoplanin can be based on the following mechanisms:<br />&bull; Modified target structure: this form of resistance has occurred particularly in Enterococcus faecium. The<br />modification is based on exchange of the terminal D-alanine-D-alanine function of the amino-acid chain in<br />a murein precursor with D-Ala-D-lactate, thus reducing the affinity to vancomycin. The responsible<br />enzymes are a newly synthesised D-lactate dehydrogenase or ligase.<br />&bull; The reduced sensitivity or resistance of staphylococci to teicoplanin is based on the overproduction of<br />murein precursors to which teicoplanin is bound.<br />Summary of product characteristics<br />Ticopex&reg; (200mg/vial)<br />Powder for solution for injection<br />Cross-resistance between teicoplanin and the glycoprotein vancomycin may occur. A number of<br />vancomycin-resistant enterococci are sensitive to teicoplanin (Van-B phenotype).</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Teicoplanin is administered by parenteral route (intravenously or intramuscularly). After intramuscular<br />administration, the bioavailability of teicoplanin (as compared to intravenous administration) is almost<br />complete (90%). After six daily intramuscular administrations of 200 mg the mean (SD) maximum<br />teicoplanin concentration (Cmax) amounts to 12.1 (0.9) mg/L and occurs at 2 hours after administration.<br />After a loading dose of 6 mg/kg administered intravenously every 12 hours for 3 to 5 administrations,<br />Cmax values range from 60 to 70 mg/L and Ctrough are usually above 10 mg/L. After an intravenous loading<br />dose of 12 mg/kg administered every 12 hours for 3 administrations, mean values of Cmax and Ctrough are<br />estimated to be around 100 mg/L and 20 mg/L, respectively.<br />After a maintenance dose of 6 mg/kg administered once daily Cmax and Ctrough values are approximately 70<br />mg/L and 15 mg/L, respectively. After a maintenance dose of 12 mg/kg once daily Ctrough values range<br />from 18 to 30 mg/L.</p><p>When administered by oral route teicoplanin is not absorbed from the gastrointestinal tract. When<br />administered by oral route at 250 or 500 mg single dose to healthy subjects, teicoplanin is not detected in<br />serum or urine but only recovered in feces (about 45% of the administered dose) as unchanged medicinal<br />product.<br />Distribution<br />The binding to human serum proteins ranges from 87.6 to 90.8% without any variation in function of the<br />teicoplanin concentrations. Teicoplanin is mainly bound to human serum albumin. Teicoplanin is not<br />distributed in red cells.<br />The volume of distribution at steady-state (Vss) varies from 0.7 to 1.4 L/kg. The highest values of Vss are<br />observed in the recent studies where the sampling period was superior to 8 days.<br />Teicoplanin distributed mainly in lung, myocardium and bone tissues with tissue/serum ratios superior to<br />1. In blister fluids, synovial fluid and peritoneal fluid the tissue/serum ratios ranged from 0.5 to 1.<br />Elimination of teicoplanin from peritoneal fluid occurs at the same rate as from serum. In pleural fluid and<br />subcutaneous fat tissue the tissue/serum ratios are comprised between 0.2 and 0.5. Teicoplanin does not<br />readily penetrate into the cerebrospinal fluid (CSF).<br />Biotransformation<br />Unchanged form of teicoplanin is the main compound identified in plasma and urine, indicating minimal<br />metabolism. Two metabolites are formed probably by hydroxylation and represents 2 to 3% of the<br />administered dose.<br />Elimination<br />Unchanged teicoplanin is mainly excreted by urinary route (80% within 16 days) while 2.7% of the<br />administered dose is recovered in feces (via bile excretion) within 8 days following administration.<br />Elimination half-life of teicoplanin varies from 100 to 170 hours in the most recent studies where blood<br />sampling duration is about 8 to 35 days.<br />Teicoplanin has a low total clearance in the range of 10 to 14 mL/h/kg and a renal clearance in the range<br />of 8 to 12 mL/h/kg indicating that teicoplanin is mainly excreted by renal mechanisms.<br />Linearity<br />Teicoplanin exhibited linear pharmacokinetics at dose range of 2 to 25 mg/kg.<br />Special populations<br />&bull; Renal impairment:<br />As teicoplanin is eliminated by renal route, teicoplanin elimination decreases according to the degree of<br />renal impairment. The total and renal clearances of teicoplanin depends on the creatinine clearance.<br />&bull; Elderly patients:<br />In the elderly population the teicoplanin pharmacokinetics is not modified unless in case of renal<br />impairment.<br />&bull; Paediatric population<br />A higher total clearance (15.8 mL/h/kg for neonates, 14.8 mL/h/kg for a mean age 8 years) and a shorter<br />elimination half-life (40 hours neonates; 58 hours for 8 years) are observed compared to adult patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Chloride<br />Sodium hydroxide</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Teicoplanin and aminoglycoside are incompatible when mixed directly and must not be mixed before<br />injection.<br />If teicoplanin is administered in combination therapy with other antibiotics, the preparation must be<br />administered separately</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Two years.

Shelf life of reconstituted solution:
Chemical and physical in-use stability of the reconstituted solution prepared as recommended
has been demonstrated for 24 hours at 2 to 8°C.
From a microbiological point of view, the medicinal product should be used immediately. If not
used immediately, inuse storage times and conditions prior to use are the responsibility of the
user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution has taken
place in controlled and validated aseptic conditions.
Shelf life of diluted medicinal product:
Chemical and physical in-use stability of the reconstituted solution prepared as recommended
has been demonstrated for 24 hours at 2 to 8°C.
From a microbiological point of view, the medicinal product should be used immediately. If not
used immediately, inuse storage times and conditions prior to use are the responsibility of the
user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution/dilution
has taken place in controlled and validated aseptic conditions.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clear Tubular Glass Vials (10R)<br />RUBBER STOPPER Chlorobutyl LYO 20 mm1319 4432/50/ grey<br />Flip off 20 mm</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product is for single use only.<br />Preparation of reconstituted solution:</p><p>powder vial. The water is slowly added to the vial which should be rotated until all the powder is<br />dissolved to avoid foaming. If foam is developed, allow the solution to stand for approximately<br />15 minutes so that the foam disappears. Only clear and yellowish solutions should be used<br />Nominal teicoplanin content of vial 200mg 400mg<br />Volume of powder vial 10ml 22ml<br />Volume containing nominal teicoplanin dose<br />(extracted by 5 mL syringe and 23 G needle)<br />3.0 ml 3.0 ml<br />The reconstituted solution may be injected directly or alternatively further diluted, or orally<br />administered.<br />Preparation of the diluted solution before infusion:<br />Ticopex can be administered in the following infusion solutions:<br />- Sodium chloride 9 mg/mL (0.9%) solution<br />- Ringer solution<br />- Ringer-lactate solution<br />- 5% dextrose injection<br />- 10% dextrose injection<br />- 0.18% sodium chloride and 4% glucose solution<br />- 0.45% sodium chloride and 5% glucose solution<br />- Peritoneal dialysis solution containing 1.36% or 3.86% glucose solution.<br />Any unused product or waste material should be disposed of in accordance with local<br />requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MS Pharma Saudi – Riyadh-kingdom of Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                09/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>